NCT00049504 2017-05-17Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerFred Hutchinson Cancer CenterPhase 2 Completed53 enrolled 10 charts
NCT00562068 2013-08-26Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell LymphomaNational Cancer Institute (NCI)Phase 1 Unknown30 enrolled